tiprankstipranks
SAMSUNG BIOLOGICS Co., Ltd. (KR:207940)
:207940
South Korea Market
207940
SAMSUNG BIOLOGICS Co., Ltd.
RESEARCH TOOLSreports

SAMSUNG BIOLOGICS Co., Ltd. (207940) Financial Statements

1 Followers

SAMSUNG BIOLOGICS Co., Ltd. Financial Overview

SAMSUNG BIOLOGICS Co., Ltd.'s market cap is currently ₩67.21T. The company's EPS TTM is $42889.19; its P/E ratio is 33.18; SAMSUNG BIOLOGICS Co., Ltd. is scheduled to report earnings on July 23, 2026, and the estimated EPS forecast is $9978.26. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₩ 4.56T₩ 3.50T₩ 3.69T₩ 3.00T₩ 1.57T
Gross Profit₩ 2.48T₩ 1.68T₩ 1.77T₩ 1.44T₩ 784.97B
Operating Income₩ 2.07T₩ 1.32T₩ 1.11T₩ 983.63B₩ 537.31B
EBITDA₩ 2.78T₩ 2.03T₩ 1.69T₩ 1.38T₩ 737.78B
Net Income₩ 1.78T₩ 1.08T₩ 857.69B₩ 798.06B₩ 393.59B
Balance Sheet
Cash & Short-Term Investments₩ 1.46T₩ 1.33T₩ 2.06T₩ 3.19T₩ 1.37T
Total Assets₩ 11.06T₩ 17.34T₩ 16.05T₩ 16.58T₩ 7.97T
Total Debt₩ 928.21B₩ 1.49T₩ 1.91T₩ 2.51T₩ 1.29T
Net Debt₩ 779.36B₩ 1.10T₩ 1.54T₩ 1.62T₩ 1.25T
Total Liabilities₩ 3.61T₩ 6.43T₩ 6.22T₩ 7.60T₩ 2.98T
Stockholders' Equity₩ 7.45T₩ 10.90T₩ 9.83T₩ 8.98T₩ 4.99T
Cash Flow
Free Cash Flow₩ 856.07B₩ 281.73B₩ 560.90B₩ -56.18B₩ 33.44B
Operating Cash Flow₩ 2.25T₩ 1.66T₩ 1.67T₩ 953.05B₩ 454.60B
Investing Cash Flow₩ -1.86T₩ -1.24T₩ -1.57T₩ -3.11T₩ -933.49B
Financing Cash Flow₩ -620.50B₩ -433.79B₩ -635.05B₩ 3.00T₩ 496.62B
Currency in KRW

SAMSUNG BIOLOGICS Co., Ltd. Earnings and Revenue History

Income Statement >

SAMSUNG BIOLOGICS Co., Ltd. Debt to Assets

Balance Sheet >

SAMSUNG BIOLOGICS Co., Ltd. Cash Flow

Cash Flow >

SAMSUNG BIOLOGICS Co., Ltd. Forecast EPS vs Actual EPS

Earnings >